gavel-pills-istock-525883642-vnphotolab-
AVNphotolab / iStockphoto.com
10 August 2017Americas

USITC begins probe into CSL Behring

The US International Trade Commission (ITC) has instituted a probe into CSL Behring, a biopharmaceutical company.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
5 March 2020   Biotech company Bioverativ has accused CSL Behring of infringing three patents covering its haemophilia B treatment Alprolix.

More on this story

Americas
5 March 2020   Biotech company Bioverativ has accused CSL Behring of infringing three patents covering its haemophilia B treatment Alprolix.

More on this story

Americas
5 March 2020   Biotech company Bioverativ has accused CSL Behring of infringing three patents covering its haemophilia B treatment Alprolix.